Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Cash from Investing Activities (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Cash from Investing Activities for 5 consecutive years, with -$61000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 238.89% year-over-year to -$61000.0; the TTM value through Mar 2026 reached -$272000.0, down 140.71%, while the annual FY2025 figure was -$229000.0, 69.63% down from the prior year.
  • Cash from Investing Activities hit -$61000.0 in Q1 2026 for Phathom Pharmaceuticals, up from -$87000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$5000.0 in Q4 2024 and bottomed at -$939000.0 in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$182352.9, with a median of -$67000.0 recorded in 2022.
  • Year-over-year, Cash from Investing Activities surged 98.95% in 2024 and then crashed 1640.0% in 2025.
  • Phathom Pharmaceuticals' Cash from Investing Activities stood at -$412000.0 in 2022, then dropped by 15.29% to -$475000.0 in 2023, then soared by 98.95% to -$5000.0 in 2024, then plummeted by 1640.0% to -$87000.0 in 2025, then rose by 29.89% to -$61000.0 in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$61000.0, -$87000.0, and -$27000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.